MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TS-31-0000884
Genfo Bioceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹7.68 Cr
▲ 11% YoY
Net profit · FY 2024
₹20.54 Lakh
Net margin 2.7%
EBITDA · FY 2024
₹71.35 Lakh
EBITDA margin 9.3%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹3.5 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
33
Provident fund records
About Genfo Bioceuticals Private Limited
Data last updated:
Genfo Bioceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2013PTC089846. Its GSTIN is 36AAFCG5759A1ZO (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Rajeshwasr Reddy Ganta and Neeraja Ganta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No: 2 – 17/127/13 East Kalyanpuri, Hyderabad, Telangana, India – 500039.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.68 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹20.54 Lakh (net margin 2.7%) and EBITDA of ₹71.35 Lakh (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 5% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: GENFO Bioceuticals. As per MCA filings, the company has open charges of ₹3.5 Cr on record.
Genfo Bioceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-31-0000884). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genfobio.com.
Company Details of Genfo Bioceuticals Private Limited
CIN U51909TG2013PTC089846
Registration Number 089846
Incorporation Date 04 September 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-31-0000884
CIN History of Genfo Bioceuticals Private Limited
Genfo Bioceuticals has one previous CIN (Corporate Identification Number): U51909AP2013PTC089846. The current CIN is U51909TG2013PTC089846, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909TG2013PTC089846 | Current |
| U51909AP2013PTC089846 | Previous |
Recognitions & Rankings of Genfo Bioceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH.No: 2 – 17/127/13 East Kalyanpuri, Hyderabad, Telangana, India – 500039
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Genfo Bioceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Genfo Bioceuticals Private Limited
Genfo Bioceuticals operates one associated brand: GENFO Bioceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical and bioceuticals manufacturing focused on innovative healthcare solutions. | genfobio.com |
Business Activity of Genfo Bioceuticals Private Limited
The main business activity of Genfo Bioceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Genfo Bioceuticals Private Limited FY 2025 filings available
Genfo Bioceuticals Private Limited reported revenue of ₹7.68 Cr (up 11% YoY) for FY 2024.
Revenue · FY 2024
₹7.68 Cr ▲ 11%
Net profit · FY 2024
₹20.54 Lakh margin 2.7%
EBITDA · FY 2024
₹71.35 Lakh margin 9.3%
Compounded Annual Growth Rate (CAGR) of Genfo Bioceuticals Private Limited
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 15%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 71%
3 years · compounded
▲ 52%
5 years · compounded
▲ 21%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 11% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Genfo Bioceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹71.35 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹20.54 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Genfo Bioceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Genfo Bioceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Genfo Bioceuticals Private Limited
Genfo Bioceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeshwasr Reddy Ganta | Director | 04 Sep 2013 | 13 Years 1 Months | Current |
| Neeraja Ganta | Director | 04 Sep 2013 | 13 Years 1 Months | Current |
Peer Comparison of Genfo Bioceuticals Private Limited
Genfo Bioceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Suvishrhu Speciality Chemicals Private Limited | ₹7.72 Cr (FY 2024) | •••• | •••• | 125.0% | •••• | Thane, Maharashtra, India |
| Alchemist Remedies Private Limited | ₹7.72 Cr (FY 2025) | •••• | •••• | -38.0% | •••• | Indore, Madhya Pradesh, India |
| Ryzer Pharmaceutical Private Limited | ₹7.71 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Gandhinagar, Gujarat, India |
| Globespeciality Chemicals Private Limited | ₹7.71 Cr (FY 2025) | •••• | •••• | 167.0% | •••• | Pune, Maharashtra, India |
| Sunny Industries Pvt Ltd | ₹7.68 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Kolkata, West Bengal, India |
| Genfo Bioceuticals Private Limited this company | ₹7.68 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Hyderabad, Telangana, India |
| Energize Pharmaceuticals Private Limited | ₹7.67 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Pune, Maharashtra, India |
| Omish Laboratories Private Limited | ₹7.65 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Patna, Bihar, India |
| Agusto Formulations Private Limited | ₹7.65 Cr (FY 2024) | •••• | •••• | 32.0% | •••• | Chharwada, Gujarat, India |
| Moraceae Pharmaceuticals Private Limited | ₹7.64 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Uttar Pradesh, India |
| Vishnu Strontium Private Limited | ₹7.63 Cr (FY 2025) | •••• | •••• | -67.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
Peers are the five companies nearest above and the five nearest below Genfo Bioceuticals by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Genfo Bioceuticals Private Limited
Genfo Bioceuticals Private Limited is audited by SAI BINDU & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SAI BINDU & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Genfo Bioceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Genfo Bioceuticals Private Limited
Open charges
₹3.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2014 | Axis Bank Limited | ₹3.5 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Genfo Bioceuticals Private Limited
Genfo Bioceuticals Private Limited has a workforce of 33 employees as of Apr 07, 2024.
Employee count
33
Active EPFO establishments
1
Employee growth
-10.81%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Genfo Bioceuticals Private Limited
Genfo Bioceuticals Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Neeraja Ganta was appointed as Director on 04 Sep 2013.
AGM
Genfo Bioceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Genfo Bioceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited of Rs. 350.00 Lakh registered on 20 Nov 2014 with Charge ID 10533823 was modified on 17 Nov 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 350.00 Lakh with Charge ID 10533823 was registered on 20 Nov 2014.
Appointed
Neeraja Ganta was appointed as Director.
Appointed
Rajeshwasr Reddy Ganta was appointed as Director.
Incorporation
04 Sep 2013
Genfo Bioceuticals Private Limited was registered on 04 Sep 2013 with Roc Hyderabad & aged 13 years 1 month as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Genfo Bioceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Genfo Bioceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Genfo Bioceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Genfo Bioceuticals Private Limited
Genfo Bioceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCG5759A1ZO | Telangana | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Genfo Bioceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genfo Bioceuticals Private Limited
Genfo Bioceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 September 2013 (13+ years old) and is registered under CIN U51909TG2013PTC089846.
Genfo Bioceuticals reported revenue of ₹7.68 Cr for FY 2024 (up 11% YoY).
Genfo Bioceuticals has 2 current directors:
- Rajeshwasr Reddy Ganta - Director
- Neeraja Ganta - Director
Genfo Bioceuticals reported a net profit of ₹20.54 Lakh (net margin 2.7%) and EBITDA of ₹71.35 Lakh (EBITDA margin 9.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Genfo Bioceuticals is 15% over three years and 5% over five years. In the latest year (FY 2024) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Genfo Bioceuticals is 36AAFCG5759A1ZO, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Genfo Bioceuticals is U51909TG2013PTC089846. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genfo Bioceuticals was incorporated on 04 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Genfo Bioceuticals by revenue are Suvishrhu Speciality Chemicals Private Limited, Alchemist Remedies Private Limited, Ryzer Pharmaceutical Private Limited, Globespeciality Chemicals Private Limited, Sunny Industries Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Neeraja Ganta was appointed as Director on 04 Sep 2013. Rajeshwasr Reddy Ganta was appointed as Director on 04 Sep 2013.
Yes, Genfo Bioceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-31-0000884).